Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00012623 · ClinicalTrials.gov registry record

Improving Service Delivery Through Access Points

A clinical trial of Hypertension and Diabetes, sponsored by US Department of Veterans Affairs.

Completed
Registry status
39,481
Enrollment target
1
Study location

NCT00012623 is a study of Hypertension and Diabetes that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 39,481 participants, above the 3,423-participant average among 470 other Hypertension trials with a reported enrollment target (1053% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00012623, a study of Hypertension and Diabetes, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
39,481 participants
Enrollment target
1
Study location

Study Summary

CBOCs represent one of VA's main managed care strategies for shifting the focus of care from the inpatient to the outpatient setting and for improving the health of our nation's veterans. Hypothesis-driven research is critically needed to test the basic assumptions motivating the expansion of CBOCs throughout the VA health care system.

Study Locations (1)

Washington

  • Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR - No. Little Rock

Trial Details

FieldValue
Enrollment Target 39,481 participants
Est. Completion 2002-03

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00012623

The ClinicalTrials.gov registry entry for NCT00012623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39,481 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,423-participant average among 470 other Hypertension trials with a reported enrollment target (1053% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00012623 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00012623 about?

NCT00012623 is a clinical study titled "Improving Service Delivery Through Access Points". CBOCs represent one of VA's main managed care strategies for shifting the focus of care from the inpatient to the outpatient setting and for improving the health of our nation's veterans. Hypothesis-driven research is critically needed to test the basic assumptions motivating the expansion of CBOCs ...

What is the current status of trial NCT00012623?

This trial is currently completed. The enrollment target is 39,481 participants. Estimated completion is 2002-03.

What conditions does trial NCT00012623 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Angina.

Who is sponsoring clinical trial NCT00012623?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00012623 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.